Fame and Mortality: Evidence from a Retrospective Analysis of Singers
November 26, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Zomig, Zomig-ZMT
Synonyms :
zolmitriptan
Class :
Antimigraine agent, Serotonine 5-HT1b,1D receptor agonist
Brand Name :
Zomig, Zomig-ZMT
Synonyms :
zolmitriptan
Class :
Antimigraine agent, Serotonine 5-HT1b,1D receptor agonist
Dosage Forms & StrengthsÂ
Solution, Nasal:Â
2.5 mgÂ
5 mg Â
Tablet, Oral:Â
2.5 mgÂ
5 mg Â
Tablet disintegrating, Oral:Â
2.5 mgÂ
5 mgÂ
5 - 10
mg
at the beginning of cluster headache (max. 10 mg)
2.5
mg
Tablet
Oral
2 to 3 times a day, 2 days before the onset of menses and continue for around 7 days
No safe and efficacious dose describedÂ
Refer to adult dosingÂ
may have an increasingly adverse effect when combined with serotonin 5-HT1D receptor agonists
may increase the risk of hypertension when combined
may enhance the vasoconstricting effect of ergot Derivatives
may enhance the vasoconstricting effect of ergot Derivatives
may enhance the vasoconstricting effect of ergot Derivatives
may enhance the vasoconstricting effect of ergot Derivatives
may enhance the vasoconstricting effect of ergot Derivatives
may enhance the serotonergic effect of monoamine oxidase inhibitors
may enhance the serotonergic effect of monoamine oxidase inhibitors
may enhance the serotonergic effect of monoamine oxidase inhibitors
may enhance the serotonergic effect of monoamine oxidase inhibitors
may enhance the serotonergic effect of monoamine oxidase inhibitors
may have an increased vasoconstricting effect when combined with ergot derivatives
may have an increased vasoconstricting effect when combined with ergot derivatives
may have an increased serotonergic effect when combined with monoamine oxidase inhibitors
may have an increased serotonergic effect when combined with monoamine oxidase inhibitors
may have an increased serotonergic effect when combined with monoamine oxidase inhibitors
may have an increased serotonergic effect when combined with monoamine oxidase inhibitors
may have an increased serotonergic effect when combined with monoamine oxidase inhibitors
may have an increased vasoconstricting effect when combined with ergot derivatives
may have an increased vasoconstricting effect when combined with ergot derivatives
may have an increased vasoconstricting effect when combined with ergot derivatives
may have an increased vasoconstricting effect when combined with ergot derivatives
may have an increased vasoconstricting effect when combined with ergot derivatives
may have an increased serotonergic effect when combined with monoamine oxidase inhibitors
may have an increased serotonergic effect when combined with monoamine oxidase inhibitors
may have an increased serotonergic effect when combined with monoamine oxidase inhibitors
may have an increased serotonergic effect when combined with monoamine oxidase inhibitors
may have an increased serotonergic effect when combined with monoamine oxidase inhibitors
may have an increasingly adverse effect when combined with sumatriptan
serotonin 5-HT1D receptor agonists increase the serotonergic effect of MAO inhibitors
may have an increased serotonergic effect when combined with serotonergic agents
when zolmitriptan is coupled with lonazolac, the risk or severity of hypertension can be enhanced
when zolmitriptan is taken with zomepirac, the risk or severity of hypertension can be enhanced
dihydroergocristine may intensify the vasoconstricting activities of zolmitriptan
the risk or severity of hypertension may increase when zolmitriptan is combined with isoxicam
zolmitriptan may lower the antihypertensive activities of muzolimine
when ascorbigen is combined with zolmitriptan, its efficacy is reduced
may enhance the serotonergic effect of serotonergic agents
may enhance the risk or severity of hypertension when combined
may enhance the risk or severity of hypertension when combined
may increase the risk or severity of hypertension when combined
may have an increased hypertensive effect when combined with droxidopa
may increase the vasoconstricting effect of Serotonin 5-HT1D Receptor Agonists
the vasoconstricting activity of zolmitriptan may be increased
the risk of hypertension can be raised when zolmitriptan is used in combination
the risk of hypertension may be increased
Frequency defined:Â Â Â
>10% (significant)Â
Coronary vasospasmÂ
Angina pectorisÂ
Peripheral vascular ischemiaÂ
Splenic infarctionÂ
Heaviness Â
1% to 10%Â
Elevated blood pressureÂ
VomitingÂ
Dry mouthÂ
Abdominal painÂ
Muscle weaknessÂ
Warm sensationÂ
Cardiac rhythm disturbanceÂ
StrokeÂ
Pregnancy consideration: zolmitriptan is unsafe for pregnant women to use and it is assigned under category C.Â
Lactation: excretion of zolmitriptan in breast milk is not known. Â
Pregnancy category:Â
Patient information leafletÂ
Generic Name: ZolmitriptanÂ
Pronounced: zolmitriptan Â
Why do we use zolmitriptan?Â
Zolmitriptan is used for the treatment of cluster and migraine headaches.Â
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
